SCHEMBL7625595

SCHEMBL7625595

O=C(/C=C/c1ccc(O)cc1)C(F)(F)F

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.61
F3 P13726 2/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
HSD11B1 P28845 1/20 0.61
AKR1B10 O60218 2/20 0.59
AKR1B1 P15121 2/20 0.59
CA12 O43570 2/20 0.59
CA1 P00915 2/20 0.59
CA2 P00918 2/20 0.59
CA7 P43166 2/20 0.59
CA9 Q16790 2/20 0.59
CA14 Q9ULX7 2/20 0.59
PKM P14618 2/20 0.59
ESR1 P03372 1/20 0.59
CA3 P07451 1/20 0.59
CA4 P22748 1/20 0.59
CA6 P23280 1/20 0.59
DPP4 P27487 1/20 0.59
CA5A P35218 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7625602 1.00 TYR (0.61) TYRF3CYP2D6CYP2C9HSD11B1
SCHEMBL27628008 0.84 HSD11B1 (0.64) HSD11B1MAOBCYP1A1CYP1B1KMT2A
SCHEMBL5150867 0.82 CYP1A2 (0.62) MAOBCYP1B1CYP3A4KMT2AMMP1
SCHEMBL5856754 0.82 CYP1B1 (0.57) MAOBCYP1A1CYP1B1CYP3A4KMT2A
SCHEMBL5856758 0.82 CYP1B1 (0.57) MAOBCYP1A1CYP1B1CYP3A4KMT2A
SCHEMBL5150869 0.82 CYP1A2 (0.62) MAOBCYP1B1CYP3A4KMT2AMMP1
SCHEMBL4412144 0.82 LMNA (0.59) F3CYP2D6CYP2C9HCAR2MAOB
SCHEMBL2396441 0.82 LMNA (0.59) F3CYP2D6CYP2C9HCAR2MAOB
Coumaric Acid SCHEMBL27698040 0.81 ESR1 (0.78) TYRF3CYP2D6CYP2C9HSD11B1
Coumaric Acid SCHEMBL27623380 0.81 ESR1 (0.78) TYRF3CYP2D6CYP2C9HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6350892-B1 ENZYME INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2002-02-26 US disclosed
EP-1140791-A2 SELECTIVE CPLA 2 INHIBITORS Bristol-Myers Squibb Company (US) 2001-10-10 EP disclosed
EP-1140791-A4 SELECTIVE CPLA 2 INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2001-10-10 EP disclosed
US-6255496-B1 CYTOSOLIC PHOSPHATIDE 2-ACYLHYDROLASE ENZYME INHIBITORS; CONTROLLING INFLAMMATORY DISEASES BRISTOL-MYERS SQUIBB COMPANY 2001-07-03 US disclosed
WO-1999015129-A2 SELECTIVE cPLA2 INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-04-01 WO disclosed